212 related articles for article (PubMed ID: 29283383)
1. Targeted α Therapies for the Treatment of Bone Metastases.
Zustovich F; Barsanti R
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283383
[TBL] [Abstract][Full Text] [Related]
2. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
Cheetham PJ; Petrylak DP
Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
[TBL] [Abstract][Full Text] [Related]
3. Radiation-based approaches for therapy and palliation of advanced prostate cancer.
Lewis B; Sartor O
Curr Opin Urol; 2012 May; 22(3):183-9. PubMed ID: 22453334
[TBL] [Abstract][Full Text] [Related]
4. Radium-223 dichloride for the treatment of metastatic prostate cancer.
Turner PG; O'Sullivan J
Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
[TBL] [Abstract][Full Text] [Related]
5. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
Bruland ØS; Nilsson S; Fisher DR; Larsen RH
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
[TBL] [Abstract][Full Text] [Related]
6. Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects.
Lewis B; Chalhoub E; Chalouhy C; Sartor O
Oncology (Williston Park); 2015 Jul; 29(7):483-8. PubMed ID: 26178336
[TBL] [Abstract][Full Text] [Related]
7. Targeted radionuclides for prostate cancer bone metastases.
Ito T; Bilusic M; Chen D
Urol Oncol; 2015 Jan; 33(1):2-6. PubMed ID: 25671235
[No Abstract] [Full Text] [Related]
8. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
[TBL] [Abstract][Full Text] [Related]
9. Alpha and Beta Radiation for Theragnostics.
Song H; Sgouros G
PET Clin; 2024 Jul; 19(3):307-323. PubMed ID: 38688775
[TBL] [Abstract][Full Text] [Related]
10. Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.
; Parker C; Lewington V; Shore N; Kratochwil C; Levy M; Lindén O; Noordzij W; Park J; Saad F
JAMA Oncol; 2018 Dec; 4(12):1765-1772. PubMed ID: 30326033
[TBL] [Abstract][Full Text] [Related]
11. Radium-223 for the treatment of prostate cancer.
Hafeez S; Parker C
Expert Opin Investig Drugs; 2013 Mar; 22(3):379-87. PubMed ID: 23316941
[TBL] [Abstract][Full Text] [Related]
12. Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.
Patel CM; Wadas TJ; Shiozawa Y
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918705
[TBL] [Abstract][Full Text] [Related]
13. First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases.
Nilsson S; Larsen RH; Fosså SD; Balteskard L; Borch KW; Westlin JE; Salberg G; Bruland OS
Clin Cancer Res; 2005 Jun; 11(12):4451-9. PubMed ID: 15958630
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeting radiopharmaceuticals including radium-223.
Brady D; Parker CC; O'Sullivan JM
Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
[TBL] [Abstract][Full Text] [Related]
15. Radium-223 Therapy of Bone Metastases in Prostate Cancer.
Nilsson S
Semin Nucl Med; 2016 Nov; 46(6):544-556. PubMed ID: 27825434
[TBL] [Abstract][Full Text] [Related]
16. Targeted α-particle therapy of bone metastases in prostate cancer.
Jadvar H; Quinn DI
Clin Nucl Med; 2013 Dec; 38(12):966-71. PubMed ID: 24212441
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning.
Ahmadzadehfar H; Essler M; Rahbar K; Afshar-Oromieh A
PET Clin; 2018 Oct; 13(4):491-503. PubMed ID: 30219184
[TBL] [Abstract][Full Text] [Related]
18. Targeted alpha therapy using Radium-223: From physics to biological effects.
Marques IA; Neves AR; Abrantes AM; Pires AS; Tavares-da-Silva E; Figueiredo A; Botelho MF
Cancer Treat Rev; 2018 Jul; 68():47-54. PubMed ID: 29859504
[TBL] [Abstract][Full Text] [Related]
19. Radium-223: down to the bone, and less is more.
Chang AJ; Roach M
Oncology (Williston Park); 2012 Apr; 26(4):342, 344. PubMed ID: 22655526
[No Abstract] [Full Text] [Related]
20. Where Do We See Alpha Emitters in Clinical Practice? A Radiation Oncology Perspective.
O'Sullivan JM
J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S31-S33. PubMed ID: 31427257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
